UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
Read more on Pittsburgh Business Times.
Pittsburgh Business Times: UPMC Enterprises invests in prescription analytics company RxAnte
Related Resources
More Resources
12.10.19
RxEffect Series Week 4: Utilizing automated reporting to maximize intervention effectiveness
Blog Post
In our final post of the series, we describe how our platform provides operational performance reporting to help maximize the overall effectiveness of your interventions. We understand plans need to streamline operational efforts to save time and valuable resources.
11.27.19
RxEffect Series Week 3: Enabling an agile and effective adherence program
Blog Post
RxEffect is your configurable workflow and reporting solution. By offering the unique opportunity to address a wide range of measures related to prescribing, medication safety, or medication adherence including triple weighted measures, SUPD, and SPC opportunities, you can focus your efforts on providing the highest quality care to patients.
11.13.19
RxEffect Series Week 2: Delivering real-time monitoring of each patient’s refill behavior, and continuously optimized call priority lists
Blog Post
A common challenge we hear is how to ensure you are utilizing the most updated information to have the most effective conversations with patients. Despite best efforts, your team may not be aware of changes in patient fill behavior if they are not updated in real-time.